These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6258008)
41. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man. Sowers JR; Glub MS; Eggena PH; Catania RA J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264 [TBL] [Abstract][Full Text] [Related]
42. Adrenocorticotropin-mediated effect of metoclopramide on plasma aldosterone in man. Nishida S; Matsuki M; Nagase Y; Horino M; Endoh M; Kakita K; Tenku A; Oyama H J Clin Endocrinol Metab; 1983 Nov; 57(5):981-5. PubMed ID: 6311868 [TBL] [Abstract][Full Text] [Related]
43. Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion. Nishida S; Matsuki M; Adachi N; Horino M; Yoneda M; Endoh M; Oyama H; Kikuoka M; Otsuka R; Ishii R J Clin Endocrinol Metab; 1987 May; 64(5):995-1001. PubMed ID: 3031125 [TBL] [Abstract][Full Text] [Related]
44. Possible mechanism of action of metoclopramide-induced aldosterone secretion: in vivo and in vitro studies in the sheep. Wilson TA; Kaiser DL; Peach MJ; Wright EM; Carey RM Endocrinology; 1983 Sep; 113(3):887-92. PubMed ID: 6307670 [TBL] [Abstract][Full Text] [Related]
45. Arterial hypertension in acromegaly: altered dopaminergic control of aldosterone secretion. Słowińska-Srzednicka J; Puciłowska J; Zgliczyński S Clin Exp Hypertens A; 1987; 9(11):1843-58. PubMed ID: 2830067 [TBL] [Abstract][Full Text] [Related]
46. Lack of effect of prolactin inhibition by alpha-bromoergocriptine (CB 154) on plasma aldosterone in anephric and non-nephrectomized patients on regular haemodialysis. Olgaard K; Hagen C; Madsen S; Hummer L Acta Endocrinol (Copenh); 1977 Jul; 85(3):587-94. PubMed ID: 194447 [TBL] [Abstract][Full Text] [Related]
47. The effect of neostigmine on metoclopramide-induced aldosterone secretion after the administration of muscarinic antagonists in man. Sommers DK; Meyer EC; van Wyk M Eur J Clin Pharmacol; 1990; 38(4):401-3. PubMed ID: 2344865 [TBL] [Abstract][Full Text] [Related]
49. [The effect of metoclopramide, a dopamine inhibitor, on aldosterone secretion in patients with primary aldosteronism]. Mizuno K; Yaginuma K; Yamazaki M; Fukuchi S Nihon Naibunpi Gakkai Zasshi; 1982 Aug; 58(8):976-83. PubMed ID: 6292008 [No Abstract] [Full Text] [Related]
50. Reduced response to metoclopramide and anomalous rising response to upright posture of plasma aldosterone concentration in Japanese patients with aldosterone-producing adenoma. Mune T; Morita H; Yasuda K; Yamakita N; Miura K J Clin Endocrinol Metab; 1993 Oct; 77(4):1020-7. PubMed ID: 8408449 [TBL] [Abstract][Full Text] [Related]
51. Dopaminergic modulation of aldosterone secretion in the normal menstrual cycle. Garcia-Robles R; Ruilope LM; Tovar J; de Pablos P; Parada J; Hurtado A; Miranda B; Fernandez Vazquez G; Rodicio JL; Sancho J J Clin Hypertens; 1987 Dec; 3(4):470-8. PubMed ID: 3134515 [TBL] [Abstract][Full Text] [Related]
52. Effect of metoclopramide-induced prolactin on aldosterone secretion in normal subjects. Ogihara T; Matsumura S; Onishi T; Miyai K; Uozumi T Life Sci; 1977 Feb; 20(3):523-6. PubMed ID: 839976 [No Abstract] [Full Text] [Related]
53. Altered dopaminergic modulation of prolactin and aldosterone secretion in pseudohypoparathyroidism. Sowers JR; Brickman AS; Asp N; Tuck ML; Jasberg K; Magnone S J Clin Endocrinol Metab; 1981 May; 52(5):914-8. PubMed ID: 7014587 [TBL] [Abstract][Full Text] [Related]
54. Dopaminergic modulation of aldosterone secretions on changes of sodium intake in aldosterone-producing adenoma. Wu KD; Chen YM; Chu TS; Chueh SC; Tsai GC; Tseng YZ; Hsieh BS Am J Hypertens; 2002 Jul; 15(7 Pt 1):609-14. PubMed ID: 12118908 [TBL] [Abstract][Full Text] [Related]
55. Metoclopramide stimulates kaliuresis during felodipine without affecting its natriuresis. van Hamersvelt HW; Wetzels JF; Koene RA; Huysmans FT Hypertension; 1994 Nov; 24(5):633-9. PubMed ID: 7960025 [TBL] [Abstract][Full Text] [Related]
56. Dissociation of the diurnal variation of aldosterone and cortisol in anephric subjects. Cooke CR; Whelton PK; Moore MA; Caputo RA; Bledsoe T; Walker WG Kidney Int; 1979 Jun; 15(6):669-75. PubMed ID: 572442 [TBL] [Abstract][Full Text] [Related]
57. Calcium-dependent aldosterone secretion in anephric and nonnephrectomized patients on regular hemodialysis. Olgaard K; Madsen S; Hammer M; Ladefoged J J Clin Endocrinol Metab; 1978 May; 46(5):740-6. PubMed ID: 233632 [TBL] [Abstract][Full Text] [Related]
58. Metoclopramide does not inhibit atrial natriuretic factor-stimulated diuresis in man. Farrow S; Mahayni A; Banta G; Sowers J; Lockette W Aviat Space Environ Med; 1996 Mar; 67(3):248-52. PubMed ID: 8775403 [TBL] [Abstract][Full Text] [Related]
59. The effect of pizotifen, a serotonin antagonist, and of pirenzepine, a muscarinic antagonist, on hormonal responses to metoclopramide in healthy subjects. Jungmann E; Althoff PH; Hermann GJ; Schöffling K Arzneimittelforschung; 1984; 34(9):1022-4. PubMed ID: 6391497 [TBL] [Abstract][Full Text] [Related]